These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 3529529)
21. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Arima T; Lehmann M; Flye MW Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332 [TBL] [Abstract][Full Text] [Related]
22. The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat. Yamaguchi Y; Harland RC; Wyble C; Bollinger RR Transplantation; 1989 Jan; 47(1):171-7. PubMed ID: 2643224 [TBL] [Abstract][Full Text] [Related]
24. The persistence of regulatory cells developing after rat spontaneous liver acceptance. Asakura H; Takayashiki T; Ku G; Flye MW Surgery; 2005 Aug; 138(2):329-34. PubMed ID: 16153444 [TBL] [Abstract][Full Text] [Related]
25. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides. Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717 [TBL] [Abstract][Full Text] [Related]
26. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts. Boyle MJ; Dumble LJ Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348 [TBL] [Abstract][Full Text] [Related]
27. Induction of specific unresponsiveness to rat islet allografts by intrathymic UVB donor spleen cells. Oluwole SF; Jin MX; Chowdhury NC; James T; Fawwaz RA Transplantation; 1993 Nov; 56(5):1142-7. PubMed ID: 8249115 [TBL] [Abstract][Full Text] [Related]
28. Induction of donor-specific unresponsiveness to rat cardiac allografts by pretreatment with intrathymic donor MHC class I antigens. Oluwole SF; Chowdhury NC; Fawwaz RA Transplantation; 1993 Jun; 55(6):1396-402. PubMed ID: 8516825 [TBL] [Abstract][Full Text] [Related]
29. [Effects of portal venous administration with allogenic cells on renal allograft survival in the rat]. Hamashima T; Yoshimura N; Matsui S; Lee CJ; Oka T Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1752-7. PubMed ID: 2480516 [TBL] [Abstract][Full Text] [Related]
30. Variable allograft responses to pretreatment with donor splenocytes treated with mitomycin C in the rat. Yamaguchi Y; Harland R; Wyble C; Mori K; Bollinger RR Transplantation; 1989 Feb; 47(2):360-3. PubMed ID: 2493180 [TBL] [Abstract][Full Text] [Related]
31. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes. Majoor GD; Van Breda Vriesman PJ Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632 [TBL] [Abstract][Full Text] [Related]
32. Frequency and functional characterization of specific T-helper cells infiltrating rat kidney allografts during acute rejection. Manca F; Ferry B; Jaakkola M; Halttunen J; Horsmanheimo L; Häyry P Scand J Immunol; 1987 Mar; 25(3):255-64. PubMed ID: 2951845 [TBL] [Abstract][Full Text] [Related]
33. Specific immunosuppression by postoperative infusion of allogeneic spleen cells: requirement of donor major histocompatibility complex expression and graft-versus-host reactivity. Tsui TY; Deiwick A; Ko S; Schlitt HJ Transplantation; 2000 Jan; 69(1):25-30. PubMed ID: 10653375 [TBL] [Abstract][Full Text] [Related]
34. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms. Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293 [TBL] [Abstract][Full Text] [Related]
35. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Shizuru JA; Seydel KB; Flavin TF; Wu AP; Kong CC; Hoyt EG; Fujimoto N; Billingham ME; Starnes VA; Fathman CG Transplantation; 1990 Sep; 50(3):366-73. PubMed ID: 1976282 [TBL] [Abstract][Full Text] [Related]
36. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: in situ splenic distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient. Goto M; Yamaguchi Y; Matsuno K; Takata N; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M J Surg Res; 1996 Jan; 60(1):216-23. PubMed ID: 8592417 [TBL] [Abstract][Full Text] [Related]
37. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats. van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090 [TBL] [Abstract][Full Text] [Related]
38. Pretreatment with lymphocyte subpopulations and renal allograft survival in the rat. Cranston D; Wood KJ; Carter N; Morris PJ Transplantation; 1987 Jun; 43(6):809-13. PubMed ID: 3296346 [TBL] [Abstract][Full Text] [Related]
39. The combined effect of perioperative donor spleen cells or KCl-extracted antigen and cyclosporine on renal allograft survival in the rat. Cranston D; Foster S; Wood KJ; Morris PJ Transplantation; 1991 Nov; 52(5):789-94. PubMed ID: 1949161 [TBL] [Abstract][Full Text] [Related]
40. Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection. Wood KJ; Hopley A; Dallman MJ; Morris PJ Transplantation; 1988 Apr; 45(4):759-67. PubMed ID: 3282359 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]